Maryland denies accused over-stenter’s bid to reclaim medical license
Coloplast
Philips, B.D., Schein, Coloplast make the list for world’s most ethical | MassDevice.com On Call
MASSDEVICE ON CALL — The 2012 list of the world’s most ethical companies included a handful of medical device makers and group purchasing organizations, according to the research-based Ethisphere Institute.
Medtronic settles off-label biliary stent lawsuit | Legal News
U.S. Attorney’s office for Massachusetts dropped a years-long inquiry into allegations that Medtronic (NYSE:MDT) promoted off-label use for its biliary stents.
The Bay State feds told Medtronic Feb. 9 that the 3-year-old investigation is no longer active, according to a regulatory filing.
The probe began in June 2008, when the Fridley, Minn.-based med-tech company received a subpoena from the U.S. attorney’s office for doucments and data related to possible off-label marketing of the stents.
Raytel and Philips to cut 85 jobs | MassDevice.com On Call
MASSDEVICE ON CALL — Sister companies Raytel Cardiac Services Inc. and Philips Remote Cardiac Services plan to cut 85 jobs from a cardiac monitoring unit in Windsor, Conn.
The companies plan to cut work related to cardiac monitoring of pacemakers, but will keep 200 employees primarily focused on monitoring irregular heartbeats.
Supreme Court considers medical patents | Legal News
The U.S. Supreme Court heard oral arguments this week in a case that could have wide-reaching implications for health care: Whether medical patents should be allowed.
At issue is the specter of doctors being sued for patent infringement based on treatment decisions derived from the scientific research underpinning the patent.
Coloplast posts 44 percent boost in sales for latest quarter | Earnings Roundup
Coloplast AS (CPH:COLO B) reported a strong third quarter, with boosts in sales and earnings for the three months ended June 30.
The quarter’s sales grew 6 percent to $503 million, compared to $475 million during the same period last year.